Skip to content

Clinical trials

Active, not recruiting Phase 1/2 trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Active, not recruiting Country / region: Taiwan Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20172
20183
20194
20205
20212
20223
20231
20246

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Merck Sharp & Dohme LLC3
Amgen2
Hoffmann-La Roche2
Ascendis Pharma Oncology Division A/S1
Cho Pharma Inc.1
Cullinan Therapeutics Inc.1
Dizal Pharmaceuticals1
Eisai Inc.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung10
Breast Neoplasms3
Carcinoma, Transitional Cell3
Colorectal Neoplasms3
Neoplasm Metastasis3
Lung Neoplasms2
Lymphoma, Non-Hodgkin2
Neoplasms2
Squamous Cell Carcinoma of Head and Neck2
Biliary Tract Neoplasms1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.